The News Caravan

Tag: cervical

  • Vaccination of girls against cervical cancer likely to begin in six states in June: Sources

    Vaccination of girls against cervical cancer likely to begin in six states in June: Sources

    [ad_1]

    New Delhi; The government is likely to begin administering anti-cervical cancer vaccine in girls aged nine to 14 years in six states in June, official sources said on Sunday.

    In the first phase of the vaccination campaign, 2.55 crore girls are targeted to be administered the human papillomavirus (HPV) vaccine in Karnataka, Tamil Nadu, Mizoram, Chhattisgarh, Maharashtra and Uttar Pradesh, an official source told PTI.

    The Union Health Ministry has drawn a roadmap to roll out HPV vaccine in the universal immunisation programme and is likely to float a global tender in April for 16.02 crore doses to be procured by 2026, official sources said.

    The Serum Institute’s made-in-India vaccine against cervical cancer, CERVAVAC, was launched last month.

    Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), has written a letter to the Health Ministry its first indigenous HPV vaccine will be available in the private market at an MRP of Rs 2,000 per dose, it has been learnt. CERVAVAC will be available in two-dose glass vial presentation.

    Singh is learnt to have communicated in his letter that CERVAVAC will be supplied at an affordable rate whenever the Health Ministry floats a tender.

    Currently, only one HPV vaccine — American multinational Merck’s Gardasil — is available in the private market in single-dose pre-filled syringe presentation and its price is Rs 10,850.

    India is home to about 16 per cent of the world’s women, but it accounts for about a quarter of all cervical cancer incidences and nearly a third of global cervical cancer deaths.

    Indian women face a 1.6 per cent lifetime cumulative risk of developing cervical cancer and 1 per cent cumulative death risk from cervical cancer, officials had stated.

    According to some recent estimates, every year almost 80,000 women develop cervical cancer and 35,000 die due to it in India.

    [ad_2]
    #Vaccination #girls #cervical #cancer #states #June #Sources

    ( With inputs from www.siasat.com )

  • Serum Institute launches 1st made-in-India HPV vaccine for cervical cancer

    Serum Institute launches 1st made-in-India HPV vaccine for cervical cancer

    [ad_1]

    New Delhi: Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Tuesday announced the launch of the first made-in-India Human Papillomavirus (HPV) “CERVAVAC” vaccine, for the prevention of cervical cancer.

    The launch took place in the presence of Home Minister Amit Shah, Adar Poonawalla, and the Director of Government & Regulatory Affairs at Serum Institute of India, Prakash K Singh.

    “On the occasion of India’s National Girl Child Day and Cervical Cancer Awareness Month, @SerumInstIndia is pleased to launch the first made-in-India HPV vaccine by the hands of our Hon’ble Home Minister Shri @AmitShah Ji. @PrakashKsingh7,” tweeted Adar Poonawalla.

    ‘CERVAVAC’ is an outcome of a partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation, supported by Serum Institute of India Private Limited for the indigenous development of quadrivalent vaccine through its partnership programme ‘Grand Challenges India’.

    Earlier in December last, Dr NK Arora, chairman of the Covid working group, National Technical Advisory Group on Immunisation (NTAGI) had said that it is expected India to get the HPV vaccine, by April at one-tenth cost.

    Speaking to ANI, Dr Arora said, “There are two or three companies which are in the process (of manufacturing the vaccine in India) but the Serum Institute of India (SII) has already got the regulators’ clearance and the vaccine should be available for our patients by April or May 2023.”

    “The vaccine should be available soon. I don’t know the exact cost yet but am given to understand that the cost of the vaccine will be one-tenth of the internationally-branded vaccine currently available,” he added.

    Dr Arora further informed that almost 80,000 cases of cervical cancer occur in India every year.

    “During the last 24 hours, our country lost 95-100 women due to cervical cancer. India accounts for the bulk of deaths from cervical cancer in the world. Almost 80,000 cases are reportedly worldwide every year. What is important to note here is that cervical cancer is entirely preventable through vaccination. The Human Papilloma Virus or HPV causes cervical cancer and a vaccine is available which can prevent it,” he added.

    He said the Union government will be able to roll out the HPV vaccine as part of its national health programme for girls aged between 9 and 14 years.

    [ad_2]
    #Serum #Institute #launches #1st #madeinIndia #HPV #vaccine #cervical #cancer

    ( With inputs from www.siasat.com )